Molecular Docking Studies of Secondary Metabolites against Sequestosome-1 to Treat Parkinson Disease
Parkinson’s disease (PD) is one of the major progressive neurological disorders. It occurs due to a low level of achemical substance in the brain known as Dopamine, which controls the muscle movements of the body. In many cases, PDoccurs due to a low level of dopamine. PD generally appears in persons between the ages of […]